^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.

^e Tested in dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.

^f Tested in sterile water for injection.

^g Tested in dextrose 5% in sodium chloride 0.9%.

^h Lyophilized formulation tested.

ⁱ Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^j Test performed using the formulation WITHOUT edetate disodium.

^k Tested in combination with hydrocortisone sodium succinate (Upjohn) 100 mg/L.

^l Tested in combination with heparin sodium (Riker) 1000 units/L.

^m Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

ⁿ Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^o Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^p Test performed using the formulation WITH edetate disodium.

^q Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^r Tested in dextrose 10%.

^s Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^t Tested with epinephrine 16 or 64 mcg/mL in sodium chloride 0.9%.

^u Tested with norepinephrine bitartrate 16 or 64 mcg/mL in sodium chloride 0.9%.

^v Tested with insulin human (Lilly) 16 units/mL in sodium chloride 0.9%.

^w Tested with dextrose 10 or 50% plus one of the following: Ringer’s injection, lactated; sodium chloride 0.9%; or Plasma-Lyte A.